论文信息 - Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab - 字舞流文

Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab

P. Rossini | M. Mirabella | V. Nociti | D. Plantone | G. Frisullo | Anna Fetta | A. K. Patanella | A. Batocchi | A. Marti | C. De Fino | A. Bianco